Mirati Will Continue To Shine As It Keeps Delivering Promising Results [Seeking Alpha]
Mirati Therapeutics, Inc. (MRTX)
Last mirati therapeutics, inc. earnings: 2/25 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.mirati.com/node/5806
Company Research
Source: Seeking Alpha
SummaryMirati achieves positive results in phase 2 open-label study using sitravatinib to treat patients with metastatic or advanced urothelial carcinoma who have the KRAS mutation.Sitravatinib is a multi-kinase drug that targets RTK pathway which includes TAM family, VEGFR2 and KIT; This drug helps checkpoint inhibitors overcome the resistance of the tumor microenvironment.MRTX849 is a KRAS G12C inhibitor being used alone or in combination with other drugs like some checkpoint inhibitors to treat several types of cancer that have the KRAS mutation.A presentation of the basket phase 1/2 KRYSTAL study using monotherapy MRTX849 for the treatment of patients with NSCLC, colorectal cancer and pancreatic cancer will be shown at the Triple (EORTC-NCI-AACR) meeting October 2020.Mirati TherapeuticsA Look Into Multi-Kinase Targeting And Delivering With Solid ResultsThe most recent data readout comes from a phase 2 open-label study which used sitravatinib in combination with Opdivo to treat pat
Show less
Read more
Impact Snapshot
Event Time:
MRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRTX alerts
High impacting Mirati Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics